These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27588483)

  • 21. Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression.
    Ma-On C; Sanpavat A; Whongsiri P; Suwannasin S; Hirankarn N; Tangkijvanich P; Boonla C
    Med Oncol; 2017 Apr; 34(4):57. PubMed ID: 28281193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5.
    Weng X; Wu J; Lv Z; Peng C; Chen J; Zhang C; He B; Tong R; Hu W; Ding C; Cao L; Chen D; Wu J; Zheng S
    EBioMedicine; 2019 Jun; 44():225-236. PubMed ID: 31109829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway.
    Liu L; Dong Z; Liang J; Cao C; Sun J; Ding Y; Wu D
    Oncogene; 2014 Feb; 33(7):909-20. PubMed ID: 23812429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT.
    Noh JH; Bae HJ; Eun JW; Shen Q; Park SJ; Kim HS; Nam B; Shin WC; Lee EK; Lee K; Jang JJ; Park WS; Lee JY; Nam SW
    Cancer Res; 2014 Mar; 74(6):1728-38. PubMed ID: 24448241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
    Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
    Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
    Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
    Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
    Wu L; Zheng J; Chen P; Liu Q; Yuan Y
    Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
    Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
    Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
    Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
    Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
    Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
    Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
    Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
    BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients.
    Ruan J; Zheng H; Rong X; Rong X; Zhang J; Fang W; Zhao P; Luo R
    Mol Cancer; 2016 Feb; 15():17. PubMed ID: 26896959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of cetuximab and rapamycin enhances the therapeutic efficacy in hepatocellular carcinoma.
    Geng J; Li X; Lang X; Qiao C; Hu M; Yang J; Feng J; Lv M
    Technol Cancer Res Treat; 2014 Aug; 13(4):377-85. PubMed ID: 24325131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.
    Shen G; Rong X; Zhao J; Yang X; Li H; Jiang H; Zhou Q; Ji T; Huang S; Zhang J; Jia H
    Carcinogenesis; 2014 Dec; 35(12):2748-55. PubMed ID: 25280563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in autophagy-induced hepatocellular carcinoma.
    Zhou J; Zhang X; Tang H; Yu J; Zu X; Xie Z; Yang X; Hu J; Tan F; Li Q; Lei X
    Clin Chim Acta; 2020 Jul; 506():1-8. PubMed ID: 32109431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma.
    Li L; Xie D; Yu S; Ma M; Fan K; Chen J; Xiu M; Xie K; Li Y; Gao Y
    Cancer Res; 2024 Sep; 84(17):2776-2791. PubMed ID: 38885324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis.
    Haque E; Karim MR; Salam Teeli A; Śmiech M; Leszczynski P; Winiarczyk D; Parvanov ED; Atanasov AG; Taniguchi H
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo.
    Fang F; Yang L; Tao Y; Qin W
    Cancer; 2012 Jan; 118(1):134-46. PubMed ID: 21713761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.